Genetic testing for mutations in BRCA1 or BRCA2 identifies women at a high-risk of developing breast cancer; however, to date the only highly effective primary breast cancer prevention strategy is prophylactic bilateral mastectomy [4–6]. The gene discussed is BRCA2; the disease is breast cancer.